Source notes
Checked October 5, 2026. Provider pages document advertised terms. Study summaries identify the scope of our review.
- FDA — creating and keeping a medication listPatient safety and medication records
- FDA — safely using sharps at home, work and while travelingSharps disposal safety
- NIA — questions for a medical checkupPatient communication
- NIA — talking with your doctor worksheetsAppointment preparation tools
- FDA — prescription medicine labeling FAQProduct document context
- FDA — compounding questions and answersRegulatory context
- FDA — unapproved GLP-1 drug concernsSafety information
- CoreAge Rx — semaglutide offerProvider page
- CoreAge Rx — tirzepatide offerProvider page
- CoreAge Rx — pricing and plansProvider terms
- SuperHealthy Rx — current GLP-1 promotionProvider offer
- Likeness Rx — GLP-1 plan informationProvider offer and billing terms
- Ro — Body program and pricingProvider membership
- Noom Med — program pricingProvider offer; branded pathway reviewed
- Noom — branded-medication prescriptionsProvider pharmacy and follow-up process
- Found — plan offer termsProvider contract; branded plan reviewed